A glycolytic phenotype is associated with prostate cancer progression and aggressiveness: a role for monocarboxylate transporters as metabolic targets for therapy

Publisher： John Wiley & Sons Inc

E-ISSN： 1555-2039|236|4|517-530

ISSN： 0022-3417

Source： THE JOURNAL OF PATHOLOGY, Vol.236, Iss.4, 2015-08, pp. : 517-530

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Genomic Signatures Associated with the Development, Progression, and Outcome of Prostate Cancer

By Mendiratta Prateek   Febbo Phillip G.  

Molecular Diagnosis & Therapy, Vol. 11, Iss. 6, 2007-01 ,pp. : 345-354

Adis International

Access to resources Recommend Favorite

Metabolic changes in patients with prostate cancer during androgen deprivation therapy

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 25, Iss. 1, 2018-01 ,pp. : 45-53

John Wiley & Sons Inc

Access to resources Recommend Favorite

Activation of nuclear factor κB pathway and downstream targets survivin and livin by SHARPIN contributes to the progression and metastasis of prostate cancer

By  

CANCER, Vol. 120, Iss. 20, 2014-10 ,pp. : 3208-3218

John Wiley & Sons Inc

Access to resources Recommend Favorite

Increased Prostate-Specific Antigen in Subclinical Prostatitis: The Role of Aggressiveness and Extension of Inflammation

By  

Urologia Internationalis, Vol. 71, Iss. 2, 2003-08 ,pp. : 160-164

Karger

Access to resources Recommend Favorite

Local treatment of high risk prostate cancer: Role of surgery and radiation therapy

By  

CANCER, Vol. 120, Iss. 11, 2014-06 ,pp. : 1608-1610

John Wiley & Sons Inc

Access to resources Recommend Favorite